The collection of indirect and nonmedical direct costs (COIN) form: A new tool for collecting the invisible costs of androgen independent prostate carcinoma Academic Article uri icon


MeSH Major

  • Adenocarcinoma
  • Antineoplastic Agents
  • Bone Neoplasms
  • Cost of Illness
  • Prostatic Neoplasms


  • In this pilot project, the collection of these cost data using the COIN form was feasible and practical and was limited primarily by logistic, not form specific, issues. DNM/IC were found to be a significant proportion of total costs (up to 42%) in selected patients, and this information proved to be a useful addition to the cost analysis. Approximately 98 patients would be required to detect a 20% difference in total costs between arms in a properly powered, randomized trial. Considering the potentially significant impact on total costs, DNM/IC data should be included in future cost-analysis studies of patients with AIPC and other diseases.

publication date

  • February 15, 2001



  • Academic Article



  • eng

PubMed ID

  • 11241254

Additional Document Info

start page

  • 841

end page

  • 53


  • 91


  • 4